Vimarsana
Biggest News Aggregation in the World

Page 5 - Pharmaxis Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaxis Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaxis Ltd Today - Breaking & Trending Today

Pharmaxis says majority of patients in fibrosis trial see significant improvement - Vimarsana News

Pharmaxis says majority of patients in fibrosis trial see significant improvement

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips speaks with Proactive after releasing data from a final interim analysis of 10 patients who have...

Related Topics:
Gary PhillipsPharmaxis Ltd
Pharmaxis Ltd has productive drug discovery engine for inflammatory and fibrotic diseases - Vimarsana News

Pharmaxis Ltd has productive drug discovery engine for inflammatory and fibrotic diseases

Deep Dive - Pharmaxis Ltd

ASX Biotech Winners in May: We're finally seeing signs of life on the back of another clinical breakthrough - Vimarsana News

ASX Biotech Winners in May: We're finally seeing signs of life on the back of another clinical breakthrough

ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Pharmaxis Ltd extends scarring collaboration after encouraging results - Vimarsana News

Pharmaxis Ltd extends scarring collaboration after encouraging results

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company has made great progress towards commercialisation in a Phase 1C study of...

Related Topics:
Gary PhillipsPharmaxis Ltd
Pharmaxis Ltd achieves 30% reduction in scar tissue with topical LOX inhibitor in Phase 1C study; extends UWA collaboration - Vimarsana News

Pharmaxis Ltd achieves 30% reduction in scar tissue with topical LOX inhibitor in Phase 1C study; extends UWA collaboration

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has made great strides toward commercialisation in a Phase 1C study of its topical Pan LOX inhibitor, achieving...